Background: Percutaneous coronary intervention (PCI) is increasingly used to treat complex coronary artery disease; however, presently no effective risk model exists to predict long-term mortality or other major adverse cardiovascular and cerebrovascular events (MACCE) in these patients. The aim of this study was to assess whether the Clinical SYNTAX Score, (CSS) calculated by multiplying the SYNTAX Score to a modified ACEF score (age/ejection fraction +1 for each 10ml the creatinine clearance <60ml/min/1.73m2) would improve the ability of either score to predict mortality and MACCE in patients with complex coronary artery disease who were enrolled in the ARTS-II study.
